BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24470460)

  • 1. Biomarkers for the prediction of blood pressure response to renal denervation: a long way to go.
    Schlaich M
    Hypertension; 2014 May; 63(5):907-8. PubMed ID: 24470460
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation.
    Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Rixe J; Hamm C; Nef H
    Hypertension; 2014 May; 63(5):984-90. PubMed ID: 24470464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation.
    Eikelis N; Hering D; Marusic P; Walton AS; Lambert EA; Sata Y; Krum H; Lambert GW; Esler MD; Schlaich MP
    J Hum Hypertens; 2017 Apr; 31(4):248-252. PubMed ID: 27604660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and sympathetic nervous system response to renal denervation.
    Schlaich M; Hering D; Lambert G; Lambert E; Esler M
    Hypertension; 2013 Feb; 61(2):e13. PubMed ID: 23248152
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal denervation: what next?
    Joyner MJ
    Hypertension; 2014 Jul; 64(1):19-20. PubMed ID: 24732888
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity?
    Parati G; Ochoa JE; Bilo G
    Circulation; 2013 Jul; 128(4):315-7. PubMed ID: 23780577
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2014 May; 129(20):e500-1. PubMed ID: 24842939
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Wang et al.: Mechanisms for catheter-based renal denervation to lower blood pressure: personal speculation.
    Kimura G
    Hypertens Res; 2013 Nov; 36(11):1008. PubMed ID: 24067891
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal sympathetic denervation: renal function concerns.
    Petidis K; Anyfanti P; Doumas M
    Hypertension; 2011 Oct; 58(4):e19; author reply e20. PubMed ID: 21859966
    [No Abstract]   [Full Text] [Related]  

  • 10. Future of catheter-based renal denervation: key issues to solve.
    Kimura G
    Hypertens Res; 2013 Jun; 36(6):492-3. PubMed ID: 23595049
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of salt and volume retention cannot be ruled out as a mechanism underlying the blood pressure-lowering effect of renal denervation.
    Wang Y; Denton KM; Golledge J
    Hypertens Res; 2013 Nov; 36(11):1006-7. PubMed ID: 23945966
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Jin et al regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
    Jin Y; Persu A; Staessen JA
    Circulation; 2014 May; 129(20):e499. PubMed ID: 24842938
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension: Proof of concept for renal denervation.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2017 Nov; 14(11):634. PubMed ID: 28905871
    [No Abstract]   [Full Text] [Related]  

  • 14. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
    Wang Y
    Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma renalase concentration before and after radiofrequency renal denervation in patients with resistant hypertension.
    Wybraniec MT; Czerwieńska B; Lelek M; Adamczak M; Więcek A; Mizia-Stec K
    J Hum Hypertens; 2016 Jun; 30(6):410-1. PubMed ID: 26310184
    [No Abstract]   [Full Text] [Related]  

  • 16. Cochrane corner: renal denervation for resistant hypertension-a broken promise?
    Bolignano D; Coppolino G
    Heart; 2017 Nov; 103(22):1753-1755. PubMed ID: 28501794
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
    Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
    Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal denervation for sleep apnea and resistant hypertension: alternative or complementary to effective continuous positive airway pressure treatment?
    Tsioufis C; Papademetriou V; Thomopoulos C; Stefanadis C
    Hypertension; 2011 Dec; 58(6):e191; author reply e192. PubMed ID: 22042808
    [No Abstract]   [Full Text] [Related]  

  • 19. Noninvasive renal denervation for resistant hypertension using high-intensity focused ultrasound.
    Rong S; Zhu H; Liu D; Qian J; Zhou K; Zhu Q; Jiang Y; Yang G; Deng C; Zhang D; Zhou Q; Lei H; He TC; Wang Z; Huang J
    Hypertension; 2015 Oct; 66(4):e22-5. PubMed ID: 26238444
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal denervation as treatment option for hypertension].
    Blankestijn PJ; Bots ML
    Ned Tijdschr Geneeskd; 2016; 160():D629. PubMed ID: 27781967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.